Invention Grant
- Patent Title: Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same
-
Application No.: US14443617Application Date: 2013-11-20
-
Publication No.: US09963512B2Publication Date: 2018-05-08
- Inventor: Joong Kyu Kim , Jin San Yoo , Sang Hoon Lee , Weon Sup Lee , Sung Woo Kim , Sang Ryeol Shim , Jin Sang Yoo , Young Ae Lee , Mi Ju Park , Sang Soon Byun , Hyuk Joon Lee , Do Yun Kim , Yeun Ju Kim , Jin Hee Choi , Kyung Hee Nahm , Ju Ryung Nam , Jong Geun Jeong , Bo Young Jeong , Eun Jin Lee , Seon Young Lee , In Sook Park , Jin Sook Lee , Jae Bong Yoon , Nam Ye Kim , Seon Hwan Oh
- Applicant: PharmAbcine Inc.
- Applicant Address: KR Daejeon
- Assignee: PharmAbcine Inc.
- Current Assignee: PharmAbcine Inc.
- Current Assignee Address: KR Daejeon
- Agency: Hultquist, PLLC
- Agent Steven J. Hultquist
- Priority: KR10-2012-0132431 20121121
- International Application: PCT/KR2013/010589 WO 20131120
- International Announcement: WO2014/081202 WO 20140530
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/705 ; G01N33/50
Abstract:
The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.
Public/Granted literature
- US20150315277A1 DUAL-TARGET ANTIBODY TARGETING VEGFR-2 AND DLL4, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Public/Granted day:2015-11-05
Information query
